IL33336A0 - 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them - Google Patents

1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them

Info

Publication number
IL33336A0
IL33336A0 IL33336A IL3333669A IL33336A0 IL 33336 A0 IL33336 A0 IL 33336A0 IL 33336 A IL33336 A IL 33336A IL 3333669 A IL3333669 A IL 3333669A IL 33336 A0 IL33336 A0 IL 33336A0
Authority
IL
Israel
Prior art keywords
pyrazin
imidazo
ones
preparing
Prior art date
Application number
IL33336A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL33336A0 publication Critical patent/IL33336A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL33336A 1968-11-20 1969-11-10 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them IL33336A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77747868A 1968-11-20 1968-11-20

Publications (1)

Publication Number Publication Date
IL33336A0 true IL33336A0 (en) 1970-01-29

Family

ID=25110370

Family Applications (1)

Application Number Title Priority Date Filing Date
IL33336A IL33336A0 (en) 1968-11-20 1969-11-10 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them

Country Status (10)

Country Link
US (1) US3567725A (de)
AT (1) AT290528B (de)
BE (1) BE741910A (de)
BR (1) BR6914329D0 (de)
DE (2) DE1957711A1 (de)
FR (1) FR2035817B1 (de)
GB (1) GB1246006A (de)
IL (1) IL33336A0 (de)
NL (1) NL6915957A (de)
ZA (1) ZA698081B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810934D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Amides
GB8810933D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Heterocyclic compounds
US5705585A (en) * 1993-06-30 1998-01-06 Arqule, Inc. Aminimide-containing molecules and materials as molecular recognition agents
US7034110B2 (en) * 1994-01-05 2006-04-25 Arqule, Inc. Method of identifying chemical compounds having selected properties for a particular application
AU704878B2 (en) * 1994-01-05 1999-05-06 Arqule, Inc. Method of making polymers having specific properties
US5734082A (en) * 1994-10-20 1998-03-31 Arqule Inc. Hydroxyethyl aminimides
US5712171A (en) * 1995-01-20 1998-01-27 Arqule, Inc. Method of generating a plurality of chemical compounds in a spatially arranged array
WO1996031263A1 (en) * 1995-04-06 1996-10-10 Arqule, Inc. Method for rapid purification, analysis and characterization of collections of chemical compounds
US5962412A (en) * 1996-06-10 1999-10-05 Arqule, Inc. Method of making polymers having specific properties
MX337906B (es) * 2006-10-19 2016-03-28 Signal Pharm Llc Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
US8110578B2 (en) 2008-10-27 2012-02-07 Signal Pharmaceuticals, Llc Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
SG10201500511TA (en) 2009-10-26 2015-03-30 Signal Pharm Llc Methods Of Synthesis And Purification Of Heteroaryl Compounds
PH12014500869A1 (en) 2011-10-19 2014-06-30 Signal Pharm Llc Treatment of cancer with tor kinase inhibitors
KR102040997B1 (ko) 2011-12-02 2019-11-27 시그날 파마소티칼 엘엘씨 7-(6-(2-히드록시프로판-2-일)피리딘-3-일)-1-((트랜스)-4-메톡시시클로헥실)-3,4-디히드로피라지노[2,3-b]피라진-2(1H)-온, 그의 고체 형태의 제약 조성물 및 그의 사용 방법
EP2817029B1 (de) 2012-02-24 2019-07-10 Signal Pharmaceuticals, LLC Verfahren zur behandlung von nicht kleinzelligen lungenkrebs mit tor kinasehemmerkombinationstherapie
AU2013203714B2 (en) 2012-10-18 2015-12-03 Signal Pharmaceuticals, Llc Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity
PE20151995A1 (es) 2013-01-16 2016-01-13 Signal Pharm Llc Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y metodos de tratamiento con los mismos
CA2909579A1 (en) 2013-04-17 2014-10-23 Signal Pharmaceuticals, Llc Combination therapy comprising a tor kinase inhibitor and n-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide for treating cancer
CN105377299B (zh) 2013-04-17 2018-06-12 西格诺药品有限公司 用于治疗前列腺癌的包含二氢吡嗪并-吡嗪化合物和雄激素受体拮抗剂的组合疗法
CA2908742C (en) 2013-04-17 2021-06-01 Signal Pharmaceuticals, Llc Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer
US9505764B2 (en) 2013-04-17 2016-11-29 Signal Pharmaceuticals, Llc Treatment of cancer with dihydropyrazino-pyrazines
US9630966B2 (en) 2013-04-17 2017-04-25 Signal Pharmaceuticals, Llc Treatment of cancer with dihydropyrazino-pyrazines
WO2014172436A1 (en) 2013-04-17 2014-10-23 Signal Pharmaceuticals, Llc Combination therapy comprising a tor kinase inhibitor and a 5-substituted quinazolinone compound for treating cancer
CA2909629C (en) 2013-04-17 2022-12-13 Signal Pharmaceuticals, Llc Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
GB201309508D0 (en) * 2013-05-28 2013-07-10 Redx Pharma Ltd Compounds
NZ629486A (en) 2013-05-29 2017-11-24 Signal Pharm Llc Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
US9512129B2 (en) 2014-04-16 2016-12-06 Signal Pharmaceuticals, Llc Solid forms comprising 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one and a coformer
NZ714742A (en) 2014-04-16 2017-04-28 Signal Pharm Llc Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
WO2015160882A1 (en) 2014-04-16 2015-10-22 Signal Pharmaceuticals, Llc SOLID FORMS COMPRISING 7-(6-(2-HYDROXYPROPAN-2YL) PYRIDIN-3-YL)-1-(TRANS)-4-METHOXYCYCLOHEXYL)-3, 4-DIHYDROPYRAZINO[2,3-b] PYRAZIN-2(1H)-ONE, AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF
ES2823756T3 (es) 2014-04-16 2021-05-10 Signal Pharm Llc Métodos para tratar el cáncer usando terapia de combinación de inhibidores de quinasa TOR
WO2016010886A1 (en) 2014-07-14 2016-01-21 Signal Pharmaceuticals, Llc Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof
NZ629796A (en) 2014-07-14 2015-12-24 Signal Pharm Llc Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
TWI787284B (zh) 2017-06-22 2022-12-21 美商西建公司 以b型肝炎病毒感染表徵之肝細胞癌之治療

Also Published As

Publication number Publication date
BR6914329D0 (pt) 1973-02-22
AT290528B (de) 1971-06-11
BE741910A (de) 1970-05-19
NL6915957A (de) 1970-05-22
US3567725A (en) 1971-03-02
ZA698081B (en) 1971-07-28
DE1965989A1 (de) 1971-02-18
FR2035817A1 (de) 1970-12-24
FR2035817B1 (de) 1973-01-12
GB1246006A (en) 1971-09-15
DE1957711A1 (de) 1970-06-18

Similar Documents

Publication Publication Date Title
IL33336A0 (en) 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them
YU215269A (en) Process for preparing novel 11-substituted 5,11-dihydro-6h-pyrido (2,3-b) (184)benzodiazepin-6-ones
IL30463A0 (en) 1h-imidazo(4,5-beta)pyrazine-2-ones and process for their preparation
YU133669A (en) Process for preparing 2-bromo-alfa-ergocryptine
YU169669A (en) Process for preparing delta-aminocyclohexadienyl alkylene-penicillin
IL31950A (en) Alkyl-6,7-aziridino-7-deoxy-alpha-thiolincosaminides and process for preparing them
YU34529B (en) Process for preparing 1,3,4-thiadiazolyl (5)-carbamides
YU35584B (en) Process for preparing 1,1,1-trichloro etane derivatives
IL32243A (en) Process for preparing quinoxaline-di-n-oxides
YU33976B (en) Process for preparing 4,20,22-bufatrienolide-rhamnoside-ethers
IL27455A (en) 3-methyl-1h-pyrazolo(3,4-b)pyridines and process for their preparation
YU298769A (en) Process for preparing omega-cyanoalkylcarbamyl-benzimidazoles
YU123469A (en) Process for preparing novel 1,3,4-thiadiazolyl-carbamates
IL27443A (en) Isoxazolo(5,4-b)pyridines and process for preparing same
YU34354B (en) Process for preparing 4-aryl-1-(4,4-diaryl-butyl)-4hydroxypiperidines
YU188969A (en) Process for preparing corticoid-21-mono-phospahtes
YU40073A (en) Process for preparing novel 11-substituted 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepine-6-ones
YU34417B (en) Process for preparing 2,4-diamino-6-alkylthio-s-triazines
YU289578A (en) Process for obtaining imidazo (4,5-b) pyridines
YU1469A (en) Process for preparing delta-carboxybenzyl-penicillin
YU131369A (en) Process for preparing 1-benzyl-3-3dimethylaminopropoxy-1h--indazole
IL22912A (en) Pyrido(3,4-b)indoles and process for their preparation
YU155069A (en) Process for preparing p-hydroxybutyrophenones
CA891505A (en) 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing
YU107368A (en) Process for preparing and isolating 1,2-dimethyl-5-nitroimidazoles